These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 26060244

  • 1. Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury: Implications for Perioperative Neuroprotection.
    Sun YY, Li Y, Wali B, Li Y, Lee J, Heinmiller A, Abe K, Stein DG, Mao H, Sayeed I, Kuan CY.
    Stroke; 2015 Jul; 46(7):1947-55. PubMed ID: 26060244
    [Abstract] [Full Text] [Related]

  • 2. Short-term administration of a new free radical scavenger, edaravone, is more effective than its long-term administration for the treatment of neonatal hypoxic-ischemic encephalopathy.
    Noor JI, Ikeda T, Mishima K, Aoo N, Ohta S, Egashira N, Iwasaki K, Fujiwara M, Ikenoue T.
    Stroke; 2005 Nov; 36(11):2468-74. PubMed ID: 16210562
    [Abstract] [Full Text] [Related]

  • 3. Synergy of combined tPA-edaravone therapy in experimental thrombotic stroke.
    Sun YY, Morozov YM, Yang D, Li Y, Dunn RS, Rakic P, Chan PH, Abe K, Lindquist DM, Kuan CY.
    PLoS One; 2014 Nov; 9(6):e98807. PubMed ID: 24911517
    [Abstract] [Full Text] [Related]

  • 4. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain.
    Zhang N, Komine-Kobayashi M, Tanaka R, Liu M, Mizuno Y, Urabe T.
    Stroke; 2005 Oct; 36(10):2220-5. PubMed ID: 16166574
    [Abstract] [Full Text] [Related]

  • 5. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
    Ueno Y, Zhang N, Miyamoto N, Tanaka R, Hattori N, Urabe T.
    Neuroscience; 2009 Aug 18; 162(2):317-27. PubMed ID: 19409967
    [Abstract] [Full Text] [Related]

  • 6. A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model.
    Fujiwara N, Som AT, Pham LD, Lee BJ, Mandeville ET, Lo EH, Arai K.
    Neurosci Lett; 2016 Oct 28; 633():7-13. PubMed ID: 27589890
    [Abstract] [Full Text] [Related]

  • 7. Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury.
    Zhang P, Li W, Li L, Wang N, Li X, Gao M, Zheng J, Lei S, Chen X, Lu H, Liu Y.
    Neuroscience; 2012 Jan 10; 201():297-306. PubMed ID: 22116052
    [Abstract] [Full Text] [Related]

  • 8. Edaravone inhibits lipid peroxidation in neonatal hypoxic-ischemic rats: an in vivo microdialysis study.
    Noor JI, Ueda Y, Ikeda T, Ikenoue T.
    Neurosci Lett; 2007 Feb 27; 414(1):5-9. PubMed ID: 17280782
    [Abstract] [Full Text] [Related]

  • 9. Effects of the free radical scavenger, edaravone, on the development of postoperative cognitive impairment in patients undergoing carotid endarterectomy.
    Ogasawara K, Yamadate K, Kobayashi M, Endo H, Fukuda T, Yoshida K, Terasaki K, Inoue T, Ogawa A.
    Surg Neurol; 2005 Oct 27; 64(4):309-13; discussion 313-4. PubMed ID: 16182000
    [Abstract] [Full Text] [Related]

  • 10. Edaravone, a free radical scavenger, attenuates cerebral infarction and hemorrhagic infarction in rats with hyperglycemia.
    Okamura K, Tsubokawa T, Johshita H, Miyazaki H, Shiokawa Y.
    Neurol Res; 2014 Jan 27; 36(1):65-9. PubMed ID: 24074041
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia.
    Shichinohe H, Kuroda S, Yasuda H, Ishikawa T, Iwai M, Horiuchi M, Iwasaki Y.
    Brain Res; 2004 Dec 17; 1029(2):200-6. PubMed ID: 15542075
    [Abstract] [Full Text] [Related]

  • 12. Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion.
    Toyoda K, Fujii K, Kamouchi M, Nakane H, Arihiro S, Okada Y, Ibayashi S, Iida M.
    J Neurol Sci; 2004 Jun 15; 221(1-2):11-7. PubMed ID: 15178207
    [Abstract] [Full Text] [Related]

  • 13. Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury.
    Ohta M, Higashi Y, Yawata T, Kitahara M, Nobumoto A, Ishida E, Tsuda M, Fujimoto Y, Shimizu K.
    Brain Res; 2013 Jan 15; 1490():184-92. PubMed ID: 22982593
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotection of edaravone on hypoxic-ischemic brain injury in neonatal rats.
    Yasuoka N, Nakajima W, Ishida A, Takada G.
    Brain Res Dev Brain Res; 2004 Jul 19; 151(1-2):129-39. PubMed ID: 15246699
    [Abstract] [Full Text] [Related]

  • 15. Striatal neuroprotection from neonatal hypoxia-ischemia in piglets by antioxidant treatment with EUK-134 or edaravone.
    Ni X, Yang ZJ, Carter EL, Martin LJ, Koehler RC.
    Dev Neurosci; 2011 Jul 19; 33(3-4):299-311. PubMed ID: 21701140
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic time window for ischemic stroke].
    Abe K.
    Rinsho Shinkeigaku; 2011 Nov 19; 51(11):1182-4. PubMed ID: 22277527
    [Abstract] [Full Text] [Related]

  • 17. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
    Yagi K, Kitazato KT, Uno M, Tada Y, Kinouchi T, Shimada K, Nagahiro S.
    Stroke; 2009 Feb 19; 40(2):626-31. PubMed ID: 19095969
    [Abstract] [Full Text] [Related]

  • 18. Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers.
    Green AR, Ashwood T.
    Curr Drug Targets CNS Neurol Disord; 2005 Apr 19; 4(2):109-18. PubMed ID: 15857295
    [Abstract] [Full Text] [Related]

  • 19. UPEI-300, a conjugate of lipoic acid and edaravone, mediates neuroprotection in ischemia/reperfusion.
    Connell BJ, Saleh MC, Kucukkaya I, Abd-El-Aziz AS, Khan BV, Saleh TM.
    Neurosci Lett; 2014 Feb 21; 561():151-5. PubMed ID: 24394910
    [Abstract] [Full Text] [Related]

  • 20. Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4.
    Kikuchi K, Tancharoen S, Matsuda F, Biswas KK, Ito T, Morimoto Y, Oyama Y, Takenouchi K, Miura N, Arimura N, Nawa Y, Meng X, Shrestha B, Arimura S, Iwata M, Mera K, Sameshima H, Ohno Y, Maenosono R, Tajima Y, Uchikado H, Kuramoto T, Nakayama K, Shigemori M, Yoshida Y, Hashiguchi T, Maruyama I, Kawahara K.
    Biochem Biophys Res Commun; 2009 Dec 25; 390(4):1121-5. PubMed ID: 19737535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.